JBM  Vol.4 No.10 , October 2016
Deciphering the Risk Factors of Autism: Are We There Yet?
Abstract: Background: Autism represents a group of developmental disorder that pose a major challenge to world-wide societies and healthcare providers with limited diagnostics and medical cure. It is widely been considered as a mental disorder characterized by speech deficit and repetitive behavior. The presumed etiology of autism involves genetic, immunologic, intestinal and synaptic irregularities, aside from environmental toxicities. Yet, the prospective factor that triggers or predominates autism remains barely understood. Objective: Herein we aim to review the literature to identify the risk factors associated with the development of autism and the need to investigate the underlying pathological events. Results: Genetic factors have been widely investigated in autism for its role in inflammation, neuronal function, metabolism and detoxification. It’s assumed to be negatively impacted by heavy metals, allergens, infectious agents and environmental pollutants. Considering the fact that, these elements individually does not make up autism, one would expect a complex interplay of neuro inflammatory and gastrointestinal system in the pathophysiology of the disease. Gut-brain axis may serve as a potential pathological link representing the plethora of mechanistic events involved in the development of autism. Abnormal activation of mast and neuro glial cells may lead to deregulated expression of cytokines and neuroactive compounds, which may disrupt the blood brain barrier permeability leading to inflammation. Alternatively it may also interfere with intestinal permeability, gut physiology, microbial composition and related metabolites. Conclusion: A glance through the literature indicates the likelihood of genetic variations and environmental factors in triggering a cascade of inflammatory events leading to the development of autism. Though relatively little information is known regarding the factors that initiate the onset and the progression of the disease; the rising prevalence of autism across the globe alarms us towards a better know-how of the disease and the shortfalls in disease treatment and management.
Cite this paper: Nizam, R. and Fadhli, S. (2016) Deciphering the Risk Factors of Autism: Are We There Yet?. Journal of Biosciences and Medicines, 4, 65-76. doi: 10.4236/jbm.2016.410007.

[1]   Steinberg, J. and Webber, C. (2013) The Roles of FMRP-Regulated Genes in Autism Spectrum Disorder: Single- and Multiple-Hit Genetic Etiologies. The American Journal of Human Genetics, 93, 825-839.

[2]   Volkmar, F.R., State, M. and Klin, A. (2009) Autism and Autism Spectrum Disorders: Diagnostic Issues for the Coming Decade. Journal of Child Psychology and Psychiatry, 50, 108-115.

[3]   Freitag, C.M. (2007) The Genetics of Autistic Disorders and Its Clinical Relevance: A Review of the Literature. Molecular Psychiatry, 12, 2-22.

[4]   Abrahams, B.S. and Geschwind, D.H. (2008) Advances in Autism Genetics: On the Threshold of a New Neurobiology. Nature Reviews Genetics, 9, 341-355.

[5]   Xia, K., Guo, H., Hu, Z., Xun, G., Zuo, L., Peng, Y., Wang, K., He, Y., Xiong, Z., Sun, L., Pan, Q., Long, Z., Zou, X., Li, X., Li, W., Xu, X., Lu, L., Liu, Y., Hu, Y., Tian, D., Long, L., Ou, J., Liu, Y., Li, X., Zhang, L., Pan, Y., Chen, J., Peng, H., Liu, Q., Luo, X., Su, W., Wu, L., Liang, D., Dai, H., Yan, X., Feng, Y., Tang, B., Li, J., Miedzybrodzka, Z., Xia, J., Zhang, Z., Luo, X., Zhang, X., St Clair, D., Zhao, J. and Zhang, F. (2014) Common Genetic Variants on 1p13.2 Associate with Risk of Autism. Molecular Psychiatry, 19, 1212-1219.

[6]   Scheid, I., Maruani, A., Huguet, G., Leblond, C.S., Nygren, G., Anckarsater, H., Beggiato, A., Rastam, M., Amsellem, F., Gillberg, I.C., Elmaleh, M., Leboyer, M., Gillberg, C., Betancur, C., Coleman, M., Hama, H., Cook, E.H., Bourgeron, T. and Delorme, R. (2013) Heterozygous FA2H Mutations in Autism Spectrum Disorders. BMC Medical Genetics, 14, 124.

[7]   O’Roak, B.J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J.J., Girirajan, S., Karakoc, E., Mackenzie, A.P., Ng, S.B., Baker, C., Rieder, M.J., Nickerson, D.A., Bernier, R., Fisher, S.E., Shendure, J. and Eichler, E.E. (2011) Exome Sequencing in Sporadic Autism Spectrum Disorders Identifies Severe de Novo Mutations. Nature Genetics, 43, 585-589.

[8]   Jiang, Y.H., Yuen, R.K., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., Wang, G., Liang, J., Wang, Z., Cao, D., Carter, M.T., Chrysler, C., Drmic, I.E., Howe, J.L., Lau, L., Marshall, C.R., Merico, D., Nalpathamkalam, T., Thiruvahindrapuram, B., Thompson, A., Uddin, M., Walker, S., Luo, J., Anagnostou, E., Zwaigenbaum, L., Ring, R.H., Wang, J., Lajonchere, C., Wang, J., Shih, A., Szatmari, P., Yang, H., Dawson, G., Li, Y. and Scherer, S.W. (2013) Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing. The American Journal of Human Genetics, 93, 249-263.

[9]   Levy, D., Ronemus, M., Yamrom, B., Lee, Y.H., Leotta, A., Kendall, J., Marks, S., Lakshmi, B., Pai, D., Ye, K., Buja, A., Krieger, A., Yoon, S., Troge, J., Rodgers, L., Iossifov, I. and Wigler, M. (2011) Rare de Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders. Neuron, 70, 886-897.

[10]   Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y.H., Hicks, J., Spence, S.J., Lee, A.T., Puura, K., Lehtimaki, T., Ledbetter, D., Gregersen, P.K., Bregman, J., Sutcliffe, J.S., Jobanputra, V., Chung, W., Warburton, D., King, M.C., Skuse, D., Geschwind, D.H., Gilliam, T.C., Ye, K. and Wigler, M. (2007) Strong Association of de Novo Copy Number Mutations with Autism. Science, 316, 445-449.

[11]   Gupta, A.R. and State, M.W. (2007) Recent Advances in the Genetics of Autism. Biological Psychiatry, 61, 429-437.

[12]   Veenstra-Vanderweele, J., Christian, S.L. and Cook Jr., E.H. (2004) Autism as a Paradigmatic Complex Genetic Disorder. Annual Review of Genomics and Human Genetics, 5, 379-405.

[13]   Gupta, S., Aggarwal, S., Rashanravan, B. and Lee, T. (1998) Th1- and Th2-Like Cytokines in CD4+ and CD8+ T Cells in Autism. Journal of Neuroimmunology, 85, 106-109.

[14]   Singh, V.K., Warren, R., Averett, R. and Ghaziuddin, M. (1997) Circulating Autoantibodies to Neuronal and Glial Filament Proteins in Autism. Pediatric Neurology, 17, 88-90.

[15]   Theoharides, T.C., Angelidou, A., Alysandratos, K.D., Zhang, B., Asadi, S., Francis, K., Toniato, E. and Kalogeromitros, D. (2012) Mast Cell Activation and Autism. Biochimica et Biophysica Acta, 1822, 34-41.

[16]   Wei, H., Zou, H., Sheikh, A.M., Malik, M., Dobkin, C., Ted Brown, W. and Li, X. (2011) IL-6 Is Increased in the Cerebellum of Autistic Brain and Alters Neural Cell Adhesion, Migration and Synaptic Formation. Journal of Neuroinflammation, 8, 52.

[17]   Chez, M.G., Dowling, T., Patel, P.B., Khanna, P. and Kominsky, M. (2007) Elevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children. Pediatric Neurology, 36, 361-365.

[18]   El Goharya, T.M., El Azizb, N.A., Darweeshc, M. and Sadaaa, E.S. (2015) Plasma Level of Transforming Growth Factor β 1 in Children with Autism Spectrum Disorder. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 16, 69-73.

[19]   Kim, J.H., Byun, H.M., Chung, E.C., Chung, H.Y. and Bae, O.N. (2013) Loss of Integrity: Impairment of the Blood-Brain Barrier in Heavy Metal-Associated Ischemic Stroke. Toxicological Research, 29, 157-164.

[20]   Abdallah, M.W., Pearce, B.D., Larsen, N., Greaves-Lord, K., Norgaard-Pedersen, B., Hougaard, D.M., Mortensen, E.L. and Grove, J. (2012) Amniotic Fluid MMP-9 and Neurotrophins in Autism Spectrum Disorders: An Exploratory Study. Autism Research, 5, 428-433.

[21]   Ramos-Fernandez, M., Bellolio, M.F. and Stead, L.G. (2011) Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review. Journal of Stroke and Cerebrovascular Diseases, 20, 47-54.

[22]   Abdallah, M.W., Larsen, N., Grove, J., Norgaard-Pedersen, B., Thorsen, P., Mortensen, E.L. and Hougaard, D.M. (2012) Amniotic Fluid Chemokines and Autism Spectrum Disorders: An Exploratory Study Utilizing a Danish Historic Birth Cohort. Brain Behavior and Immunity, 26, 170-176.

[23]   Ghanizadeh, A. (2010) Targeting Neurotensin as a Potential Novel Approach for the Treatment of Autism. Journal of Neuroinflammation, 7, 58.

[24]   Morgan, J.T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E. and Everall, I.P. (2012) Abnormal Microglial-Neuronal Spatial Organization in the Dorsolateral Prefrontal Cortex in Autism. Brain Research, 1456, 72-81.

[25]   Rodriguez, J.I. and Kern, J.K. (2011) Evidence of Microglial Activation in Autism and Its Possible Role in Brain Underconnectivity. Neuron Glia Biology, 7, 205-213.

[26]   Ghanizadeh, A. (2013) Increased Glutamate and Homocysteine and Decreased Glutamine Levels in Autism: A Review and Strategies for Future Studies of Amino Acids in Autism. Disease Markers, 35, 281-286.

[27]   Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E. and Pevsner, J. (2001) Postmortem Brain Abnormalities of the Glutamate Neurotransmitter System in Autism. Neurology, 57, 1618-1628.

[28]   Harada, M., Taki, M.M., Nose, A., Kubo, H., Mori, K., Nishitani, H. and Matsuda, T. (2011) Non-Invasive Evaluation of the GABAergic/Glutamatergic System in Autistic Patients Observed by MEGA-Editing Proton MR Spectroscopy Using a Clinical 3 Tesla Instrument. Journal of Autism and Developmental Disorders, 41, 447-454.

[29]   Miller, M., Bales, K.L., Taylor, S.L., Yoon, J., Hostetler, C.M., Carter, C.S. and Solomon, M. (2013) Oxytocin and Vasopressin in Children and Adolescents with Autism Spectrum Disorders: Sex Differences and Associations with Symptoms. Autism Research, 6, 91-102.

[30]   Mohamed Fel, B., Zaky, E.A., El-Sayed, A.B., Elhossieny, R.M., Zahra, S.S., Salah Eldin, W., Youssef, W.Y., Khaled, R.A. and Youssef, A.M. (2015) Assessment of Hair Aluminum, Lead, and Mercury in a Sample of Autistic Egyptian Children: Environmental Risk Factors of Heavy Metals in Autism. Behavioural Neurology, 2015, Article ID: 545674.

[31]   Matter, K. and Balda, M.S. (2015) Signalling to and From Tight Junctions. Nature Reviews Molecular Cell Biology, 4, 225-236.

[32]   Fatemi, S.H., Folsom, T.D., Reutiman, T.J. and Lee, S. (2008) Expression of Astrocytic Markers Aquaporin 4 and Connexin 43 Is Altered in Brains of Subjects with Autism. Synapse, 62, 501-507.

[33]   Tian, Y., Green, P.G., Stamova, B., Hertz-Picciotto, I., Pessah, I.N., Hansen, R., Yang, X., Gregg, J.P., Ashwood, P., Jickling, G., Van de Water, J. and Sharp, F.R. (2011) Correlations between Gene Expression and Mercury Levels in Blood of Boys with and without Autism. Neurotoxicity Research, 19, 31-48.

[34]   Tian, Y., Green, P.G., Stamova, B., Hertz-Picciotto, I., Pessah, I.N., Hansen, R., Yang, X., Gregg, J.P., Ashwood, P., Jickling, G., Van de Water, J. and Sharp, F.R. (2011) Correlations of Gene Expression with Blood Lead Levels in Children with Autism Compared to Typically Developing Controls. Neurotoxicity Research, 19, 1-13.

[35]   Talbott, E.O., Marshall, L.P., Rager, J.R., Arena, V.C., Sharma, R.K. and Stacy, S.L. (2015) Air Toxics and the Risk of Autism Spectrum Disorder: The Results of a Population Based Case-Control Study in Southwestern Pennsylvania. Environmental Health, 14, 80.

[36]   Williams, P.G., Dalrymple, N. and Neal, J. (2000) Eating Habits of Children with Autism. Pediatric Nursing, 26, 259-264.

[37]   Arnold, G.L., Hyman, S.L., Mooney, R.A. and Kirby, R.S. (2003) Plasma Amino Acids Profiles in Children with Autism: Potential Risk of Nutritional Deficiencies. Journal of Autism and Developmental Disorders, 33, 449-454.

[38]   Wang, T., Shan, L., Du, L., Feng, J., Xu, Z., Staal, W.G. and Jia, F. (2015) Serum Concentration of 25-Hydroxyvitamin D in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. European Child & Adolescent Psychiatry, 25, 341-350.

[39]   Rosenfeld, C.S. (2015) Microbiome Disturbances and Autism Spectrum Disorders. Drug Metabolism and Disposition, 43, 1557-1571.

[40]   Weston, B., Fogal, B., Cook, D. and Dhurjati, P. (2015) An Agent-Based Modeling Framework for Evaluating Hypotheses on Risks for Developing Autism: Effects of the Gut Microbial Environment. Medical Hypotheses, 84, 395-401.

[41]   Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K. and Ostatnikova, D. (2015) Gastrointestinal Microbiota in Children with Autism in Slovakia. Physiology & Behavior, 138, 179-187.

[42]   Gabriele, S., Sacco, R., Altieri, L., Neri, C., Urbani, A., Bravaccio, C., Riccio, M.P., Iovene, M.R., Bombace, F., De Magistris, L. and Persico, A.M. (2016) Slow Intestinal Transit Contributes to Elevate Urinary P-Cresol Level in Italian Autistic Children. Autism Research, 9, 752-759.

[43]   Zarate, G., Gonzalez, S. and Chaia, A.P. (2004) Assessing Survival of Dairy Propionibacteria in Gastrointestinal Conditions and Adherence to Intestinal Epithelia. Methods in Molecular Biology, 268, 423-432.

[44]   Agency for Toxic Substances and Disease Registry (ATSDR) (1990) Toxicological Profile for Cresols. Public Health Service, US Department of Health and Human Services, Atlanta.

[45]   Atladóttir, H.O., Thorsen, P., Ostergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M. and Parner, E.T. (2010) Maternal Infection Requiring Hospitalization during Pregnancy and Autism Spectrum Disorders. Journal of Autism and Developmental Disorders, 40, 1423-1430.

[46]   Baron-Cohen, S., Auyeung, B., Norgaard-Pedersen, B., Hougaard, D.M., Abdallah, M.W., Melgaard, L., Cohen, A.S., Chakrabarti, B., Ruta, L. and Lombardo, M.V. (2015) Elevated Fetal Steroidogenic Activity in Autism. Molecular Psychiatry, 20, 369-376.

[47]   Crider, A., Thakkar, R., Ahmed, A.O. and Pillai, A. (2014) Dysregulation of Estrogen Receptor Beta (ERβ), Aromatase (CYP19A1), and ER Co-Activators in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects. Molecular Autism, 5, 46.